- Siemens Healthineers is a the medical technology spin-off of Siemens and went public in early 2018.
- The current fiscal year has been very challenging for the company, but overall results are better than they seem, and FY2021 should see the company return to growth.
- Long-term global healthcare trends such as demographic shift, population growth, and the increase in chronic diseases, are working in the company's favor and offer a healthy growth story.
- The company offers an attractive and growing dividend, albeit the dividend story itself is only in its infancy.
For further details see:
Siemens Healthineers: A Rising Star